Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2025 on the Potential of MRT-6160, a VAV1-directed Molecular Glue Degrader, to Treat Immune-mediated Diseases

MRT-6160 inhibited disease pathology, including proteinuria, lymphadenopathy, skin lesion formation, autoantibody production, and organomegaly, ...
Animate Times on MSN

My Hero Academia FINAL SEASON Reveals "Bakugo vs. All For One" Visual, Non-Credit OP (Type-2), and "BakugoTV 2025" Livestream

Story by Koji Uchida In this highly anticipated FINAL SEASON, Katsuki Bakugo, having been defeated by the villain Tomura ...